Anorexia Nervosa Therapeutics Market Reviewed in New GlobalData Report Published at MarketPublishers.com
12 Dec 2011 • by Natalie Aster
LONDON – Anorexia nervosa is a psychiatric disorder characterized by abnormal eating behavior, severe self-induced weight loss, and psychiatric comorbidities. People with anorexia have an extreme fear of gaining weight, which causes them to try to maintain a weight far less than normal.
The biggest challenge in treating anorexia nervosa is making the person recognize that they have an illness. The goals of treatment are to restore normal body weight and eating habits. A weight gain of 1 - 3 pounds per week is considered a safe goal. The most successful treatment is a combination of psychotherapy, family therapy, and medication.
New market research report “Anorexia Nervosa Therapeutics - Pipeline Assessment and Market Forecasts to 2018” developed by GlobalData has been recently published by Market Publishers Ltd.
Report Details:
Title: Anorexia Nervosa Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Published: December, 2011
Pages: 60
Price: US$ 3,500
The report delves into extensive research and analysis of the global anorexia nervosa therapeutics market. In particular, the study features:
- annualized 7 key markets (US, France, Germany, Italy, Spain, UK and Japan) anorexia nervosa therapeutics market revenues data (2005-2009), forecast to 2018.
- pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by the 7 key markets;
- analysis of the current and future competition in the market;
- insightful review of the key industry drivers, restraints and challenges; with each trend being independently researched to provide a qualitative analysis of its implications;
- overview of strategic competitor assessment, market characterization, unmet needs and the implications for the anorexia nervosa therapeutics market;
- analysis of key recent licensing and partnership agreements in anorexia nervosa therapeutics market.
Report Contents:
1 Table of Contents
2 Executive Summary
3 Introduction
3.1 Overview
3.2 Epidemiology
3.3 Etiology
3.4 Symptoms
3.5 Diagnosis
3.6 Pathology
3.7 Treatment and Management Pattern
3.8 Referral Pathway
4 Market Characterization
4.1 Major Markets, Market Size (2005-2010)
4.2 Major Markets, Market Forecast (2010-2018)
4.3 US Market Size (2005-2010)
4.4 US Market Forecast (2010-2018)
4.5 France Market Size (2005-2010)
4.6 France Market Forecast (2010-2018)
4.7 Germany Market Size (2005-2010)
4.8 Germany Market Forecast (2010-2018)
4.9 Italy Market Size (2005-2010)
4.1 Italy Market Forecast (2010-2018)
4.11 Spain Market Size (2005-2010)
4.12 Spain Market Forecast (2010-2018)
4.13 UK Market Size (2005-2010)
4.14 UK Market Forecast (2010-2018)
4.15 Japan Market Size (2005-2010)
4.16 Japan Market Forecast (2010-2018)
4.17 Drivers and Barriers
4.18 Opportunity & Unmet Need Analysis
4.19 Key Takeaway
5 Competitive Assessment
5.1 Overview
5.1.1 Strategic Competitor Assessment
5.2 Marketed Product Profiles
5.2.1 Marketed Drug
5.2.1.1 Overview
5.2.1.2 Efficacy
5.2.1.3 Safety
5.2.1.4 Clinical Study Details
5.2.1.5 Annual Cost of Therapy
5.2.1.6 Historical Sales
5.3 Key Takeaway
6 Pipeline Assessment
6.1 Overview
6.2 Strategic Pipeline Assessment
6.3 Pipeline Analysis by Phase of Development
6.3.1 Phase III Clinical Pipeline
6.3.2 Phase II Clinical Pipeline
6.3.3 Phase I Clinical Pipeline
6.3.4 Pre-clinical & Discovery Phase
6.4 Pipeline by Mechanism of Action
6.5 Technology Trends Analytical Framework
6.6 Clinical Pipeline by Mechanism of Action, and by Monotherapy & Combination therapy
6.7 Most Promising Drugs under Clinical Development
6.8 Most Promising Drug Profiles
6.8.1 Pipeline Drug
6.81.1 Overview
6.8.1.2 Efficacy
6.8.1.3 Safety
6.8.1.4 Clinical Study Details
6.9 Key Takeaway
8 Clinical Trials Mapping
8.1 Clinical Trials by Region/Country
8.2 Clinical Trials by Phase
8.3 Clinical Trials by Trial Status
8.4 Prominent Sponsors
8.5 Top Ten Companies Participating in Therapeutics Clinical Trials
9 Strategic Assessment
9.1 Key Events Impacting the Future Market
9.2 Future Market Competition Scenario
10 Future Players
10.1 Introduction
10.2 Company Profiles
10.2.1 Profiling of top 10 companies among late stage pipeline including deal, alliance and partnerships
10.2.3 Tabular presentation details of other companies in the pipeline
10.3 Key Takeaway
11 Licensing & Partnership Deals
12 Appendix
More new market research reports by the publisher can be found at GlobalData page.
CONTACTS
The Market Publishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970
Analytics & News
